Search & Analyze

Divi's Laboratories Ltd.

HealthcarePharmaceuticals & Drugs

www.divislabs.com BSE: 532488NSE: DIVISLAB

₹9,305.00BSE2.14%

07 Sep, 4:01 PM

₹9,305.00

₹2.47L Cr

84.45

13.99

16.19%

₹9,305.00

₹9,109.80

₹9,305.00

₹5,637.50

Customise metrics bar

Price Performance

Peer Comparison

Name
SUN PHARMA. SUNPHARMA	1,899.80	37.69	4,55,825.66	0.84	2,901.23	26.53%	15,299.88	10.46%	19.11
Divi's Laboratories Ltd. DIVISLAB	9,305.00	84.45	2,47,018.51	0.32	902.00	65.50%	3,080.00	27.80%	21.51
TORRENT PHAR TORNTPHARM	4,913.00	85.68	1,86,874.73	0.77	566.00	3.28%	4,921.00	54.85%	19.27
ZYDUSLIFE ZYDUSLIFE	1,155.00	25.53	1,15,211.69	0.09	990.20	-34.90%	8,017.00	21.96%	21.39
CIPLA LTD. CIPLA	1,395.95	33.46	1,12,773.00	0.93	785.55	-39.18%	7,119.28	2.33%	16.00
LAURUSLABS LAURUSLABS	1,868.25	92.32	1,00,943.83	0.11	362.07	123.94%	2,026.31	29.10%	18.20
LUPIN LTD. LUPIN	2,105.00	17.41	96,254.46	0.86	1,416.98	16.01%	8,276.89	32.04%	28.86
MANKIND MANKIND	2,322.05	46.95	95,911.14	0.04	574.09	29.12%	4,030.59	12.89%	13.24

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	2,303.00	2,118.00	2,338.00	2,319.00	2,585.00	2,410.00	2,715.00	2,604.00	2,831.00	3,080.00
Expenses	1,572.00	1,496.00	1,622.00	1,576.00	1,699.00	1,681.00	1,827.00	1,714.00	1,897.00	1,825.00
	731.00	622.00	716.00	743.00	886.00	729.00	888.00	890.00	934.00	1,255.00
	31.74%	29.37%	30.62%	32.04%	34.27%	30.25%	32.71%	34.18%	32.99%	40.75%
	79.00	79.00	106.00	82.00	86.00	119.00	145.00	14.00	155.00	64.00
Interest	2.00	0.00	1.00	0.00	1.00	3.00	8.00	6.00	6.00	6.00
	95.00	97.00	99.00	99.00	107.00	112.00	113.00	118.00	120.00	133.00
	713.00	604.00	722.00	726.00	864.00	733.00	912.00	780.00	963.00	1,180.00
	24.54%	28.81%	29.36%	18.87%	23.38%	25.65%	24.45%	25.26%	22.01%	23.56%
	538.00	430.00	510.00	589.00	662.00	545.00	689.00	583.00	751.00	902.00
	20.30	16.23	19.25	22.23	24.98	20.57	26.00	22.00	28.34	34.04

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
INCOME :
	8,988.19	7,819.00	7,891.00	9,313.00	10,513.00
	8,959.83	7,767.00	7,845.00	9,360.00	10,560.00
EXPENDITURE :
Increase/Decrease in Stock	-523.83	23.00	-109.00	-96.00	-285.00
Raw Material Consumed	3,490.97	3,030.00	3,238.00	3,821.00	4,378.00
Power & Fuel Cost	392.33	496.00	477.00	465.00	530.00
Employee Cost	946.16	975.00	1,094.00	1,243.00	1,442.00
Other Manufacturing Expenses	365.92	401.00	425.00	416.00	482.00
General and Administration Expenses	236.44	304.00	283.00	335.00	376.00
Selling and Distribution Expenses	127.01	114.00	90.00	136.00	145.00
Miscellaneous Expenses	43.72	55.00	141.00	73.00	50.00
	5,078.72	5,398.00	5,639.00	6,393.00	7,118.00
Operating Profit (Excl OI)	3,881.11	2,369.00	2,206.00	2,967.00	3,442.00
	115.90	345.00	339.00	354.00	507.00
	3,997.01	2,714.00	2,545.00	3,321.00	3,949.00
Interest	2.00	2.00	4.00	3.00	24.00
PBDT	3,995.01	2,712.00	2,541.00	3,318.00	3,925.00
	311.51	343.00	378.00	402.00	463.00
Profit Before Taxation & Exceptional Items	3,683.50	2,369.00	2,163.00	2,916.00	3,462.00
Exceptional Income / Expenses					-74.00
	3,683.50	2,369.00	2,163.00	2,916.00	3,388.00
Provision for Tax	723.05	545.00	563.00	725.00	820.00
	2,960.45	1,824.00	1,600.00	2,191.00	2,568.00
Extra items				0.00	0.00
Consolidated Net Profit	2,960.45	1,824.00	1,600.00	2,191.00	2,568.00
Profit Balance B/F	7,597.72	9,988.00	10,959.00	11,786.00	13,400.00
Appropriations	10,558.17	11,812.00	12,559.00	13,977.00	15,968.00
Equity Dividend %	1,500.00%	1,500.00%	1,500.00%	1,500.00%	1,500.00%
	111.53	68.83	60.38	82.68	96.91
Adjusted EPS	111.53	68.83	60.38	82.68	96.91

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	53.09	53.00	53.00	53.00	53.00
Total Reserves	11,675.09	12,714.00	13,518.00	14,916.00	16,708.00
Reserve excluding Revaluation Reserve	11,675.09	12,714.00	13,518.00	14,916.00	16,708.00
Revaluation reserve	0.00
	11,728.18	12,767.00	13,571.00	14,969.00	16,761.00
Deferred Tax Assets / Liabilities	406.93	523.00	572.00	498.00	455.00
Other Long Term Liabilities	2.87	3.00	2.00	2.00	679.00
Long Term Provisions	26.71	31.00	37.00		81.00
Total Non-Current Liabilities	436.51	557.00	611.00	500.00	1,215.00
Trade Payables	795.70	762.00	824.00	910.00	1,211.00
Other Current Liabilities	394.02	332.00	404.00	486.00	760.00
Short Term Borrowings				2.00
Short Term Provisions	1,264.72	445.00	527.00	850.00	931.00
Total Current Liabilities	2,454.44	1,539.00	1,755.00	2,248.00	2,902.00
Total Liabilities	14,619.13	14,863.00	15,937.00	17,717.00	20,878.00
Gross Block	5,624.27	6,365.00	6,760.00	7,868.00	9,413.00
Less: Accumulated Depreciation	1,299.22	1,643.00	2,021.00	2,426.00	2,885.00
Net Block	4,325.05	4,722.00	4,739.00	5,442.00	6,528.00
Capital Work in Progress	469.93	212.00	778.00	1,022.00	2,113.00
Non Current Investments	72.01	77.00	82.00	65.00	69.00
Long Term Investment	72.01	77.00	82.00	65.00	69.00
Long Term Loans & Advances	133.70	97.00	176.00	301.00	204.00
Other Non Current Assets	8.05	5.00	10.00	10.00	9.00
Total Non-Current Assets	5,008.74	5,113.00	5,785.00	6,840.00	8,923.00
Inventories	2,828.62	3,000.00	3,184.00	3,236.00	3,954.00
Sundry Debtors	2,423.88	1,793.00	2,156.00	2,731.00	2,984.00
Cash and Bank	2,818.88	4,214.00	3,980.00	3,715.00	3,414.00
Other Current Assets	29.69	28.00	38.00	39.00	142.00
Short Term Loans and Advances	1,509.32	715.00	794.00	1,156.00	1,461.00
Total Current Assets	9,610.39	9,750.00	10,152.00	10,877.00	11,955.00
Net Current Assets (Including Current Investments)	7,155.95	8,211.00	8,397.00	8,629.00	9,053.00
Total Assets	14,619.13	14,863.00	15,937.00	17,717.00	20,878.00
Contingent Liabilities	89.03	89.00	257.00	8.00	8.00
Total Debt	0.00	0.00	0.00	2.00	0.00
	441.82	481.77	512.11	564.87	632.49
Adjusted Book Value	441.82	481.77	512.11	564.87	632.49

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
	3,683.50	2,369.00	2,163.00	2,916.00	3,388.00
Adjustment	239.73	144.00	81.00	115.00	113.00
Changes In working Capital	-1,370.45	419.00	-607.00	-554.00	99.00
Cash Flow after changes in Working Capital	2,552.78	2,932.00	1,637.00	2,477.00	3,600.00
Cash Flow from Operating Activities	1,911.80	2,459.00	1,261.00	1,653.00	2,738.00
Cash Flow from Investing Activities	-2,194.92	-2,707.00	-269.00	-804.00	-2,219.00
Cash Flow from Financing Activitie	-532.44	-797.00	-799.00	-799.00	-804.00
Net Cash Inflow / Outflow	-815.56	-1,045.00	193.00	50.00	-285.00
Opening Cash & Cash Equivalents	2,030.32	1,215.00	170.00	363.00	413.00
Closing Cash & Cash Equivalent	1,214.76	170.00	363.00	413.00	128.00

Ratios

Valuation

84.45

13.99

55.13

22.00

110.18

665.36

Profitability

16.19

21.51

13.31

32.74

24.43

Leverage & Liquidity

0.00

4.12

142.17

Returns

0.32

0.54

Shareholding Pattern

Numbers in percentages

Particulars	Jun '24	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	Mar '26	Jun '26
	51.90	51.89	51.89	51.89	51.89	51.89	51.88	51.88	51.88
	37.93	38.31	38.53	38.72	38.79	39.15	39.35	39.51	39.58
	10.18	9.80	9.59	9.39	9.32	8.96	8.76	8.60	8.54
	48.10	48.11	48.11	48.11	48.11	48.11	48.12	48.12	48.12
No. of Shareholders	2,98,310	2,78,899	2,80,601	2,67,755	2,59,825	2,49,634	2,33,844	2,28,006	2,26,324

Corporate Actions

Showing: All

Date	Type	Details	Ex-Date	Record Date
2026-07-20	Board Meeting	Quarterly Results
2026-07-15	AGM
2026-05-25	Ex Dividend	Rs.30.0000 per share(1500%)Final Dividend	2026-07-24	2026-07-24

Insider Trading

Date	Person	Category	Transaction Type	Shares
2026-08-31	K Sridevi	Market	Sell	200
2026-08-28	K Sridevi	Market	Sell	200
2026-08-13	Divi Madhusudana Rao	12-Aug-26	Market	20,000
2026-08-12	K Sridevi	12-Aug-26	Market	200
2026-08-10	Donepudi Venkata Sohini	Market	Buy	351
2026-07-01	Donepudi Venkata Sohini	Market	Buy	351
2026-07-01	Nimmagadda Venkata Anirudh	Market	Sell	4,200
2026-06-06	Nimmagadda Venkata Anirudh	Market	Sell	15,800
2026-06-03	D Radhika	Market	Buy	400
2026-05-30	V PARDHA SARADHI	Gift	Sell	1,000
2026-05-30	Naga Vani	Gift	Buy	1,000

Sector Overview

HealthcarePharmaceuticals & Drugs

Divi's Laboratories Ltd. operates in the Healthcare sector under the Pharmaceuticals & Drugs industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

11 members across the board and senior leadership

M Satish Choudhury

Company Secretary & Compliance Officer

—

Murali K Divi

Managing Director

₹100.26 Cr

Mar '26

N V Ramana

Executive Director

₹51.20 Cr

Mar '26

Kiran S Divi

Whole Time Director & Chief Executive Officer

₹34.84 Cr

Mar '26

Nilima Prasad Divi

Whole Time Director - Commercial

₹34.78 Cr

Mar '26

S Devendra Rao

Whole Time Director - Manufacturing

₹3.26 Cr

Mar '26

Ramesh BV Nimmagadda

Chairman

₹37.00 L

Mar '26

S Ganapaty

Non Executive Independent Director

₹34.00 L

Mar '26

K V Chowdary

Non Executive Independent Director

₹33.00 L

Mar '26

Rajendra Kumar Premchand

Non Executive Independent Director

₹28.00 L

Mar '26

Sunaina Singh

Non Executive Independent Director

₹29.00 L

Mar '26

DIVISLAB Latest News

News

7 of 7 articles

EQUITY31 Jul 2026 · 09:35

Divi's Laboratories informs about cessation of SMP

EQUITY24 Jul 2026 · 10:40

Divi's Laboratories informs about earnings call

EQUITY20 Jul 2026 · 09:35

Divi's Laboratories informs about board meeting

EQUITY13 Jul 2026 · 17:15

Divis Laboratories informs about AGM

EQUITY11 Jun 2026 · 11:23

Divis Laboratories informs about deduction of Income tax at source from payment of dividend

COMPANY25 May 2026 · 12:58

Divi's Laboratories’ consolidated net profit rises 13% in Q4

The total consolidated income of the company has increased by 11.79% at Rs 2,986.00 crore for Q4FY26

EQUITY23 May 2026 · 12:12

Divi's Lab reports Profit after tax of Rs 7560.00 Mln, in the March 2026 quarter

DIVISLAB

₹9,305.00

+2.14%